Related Experiment Video
Updated: Aug 16, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Hypercalcemia in patients treated with CAPD
Grazyna Orłowska-Kowalik1, Andrzej Ksiazek
1Chair and Department of Nephrology, Skubiszewski Medical University of Lublin.
Abstract:
The aim of this study was to examine the frequency of the occurence of hypercalcemia in patients treated with CAPD using solutions with the calcium concentration Ca 1.75 mmol/l and Ca 1.25 mmol/l. The study was performed on 11 patients treated with CAPD and lasted 48 weeks. The patients were treated with the calcium dialysate solutions Ca 1.75 mmol/l for 24 weeks. Then they swiched to Ca 1.25 mmol/l. The study was performed at the begining (0) after 2, 12 and 24 weeks of treatment with each kind of dialysate solutions. The measurements of only total calcium revealed three episodes of hypercalcemia--one in the 12th week and two in the 24th week. While the measurements of ionised calcium were performed we diagnosed 12 episodes of hypercalcemia. Four in each examined period--in the 2nd, 12th, 24th week. We did not observe the episodes of hypercalcemia during the treatment with the dialysate solution Ca 1.25 mmol/l.
Related Concept Videos
Skeleton and Calcium Homeostasis
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis III: Nursing Management
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...